PeterWymanWilsonMD

PubMed

• 1 citations
  Large-scale multi-omics identifies drug targets for heart failure with reduced and preserved ejection fraction.
  Danielle Rasooly, Claudia Giambartolomei, Gina M Peloso, Hesam Dashti, Brian R Ferolito
  Nature Cardiovascular Research. 2025-02-06
• Association of Life's Essential 8 With Incident Heart Failure and Its Prognosis.
  Yanping Li, Xuan-Mai T Nguyen, Timothy Treu, Dong D Wang, Yuk-Lam Ho
  Journal of Cardiac Failure. 2025-02-05
• Comparison of methods for building polygenic scores for diverse populations.
  Sophia Gunn, Xin Wang, Daniel C Posner, Kelly Cho, Jennifer E Huffman
  HGG Advances. 2025-01-09

Journal Articles

• prediction of coronary heart disease  
  Wilson, P.W., Circulation, 1998

Books/Book Chapters

• Dyslipidaemia in Clinical Practice 
  Wilson PWFEditors: Thompson G, Morrell J, Wilson P.Informa HealthcareEdition 2nd,2006
• Atlas of Cardiovascular Risk Factors 
  Chapter: Coronary heart disease risk: Origins, factors and utility. 
  Page 37 - 48Wilson PWFEditors: Gaziano JM.Current Medicine2006
• Women and Heart Disease 
  Chapter: Cardiovascular disease risk factors in women 
  Page 17 - 31Wilson PWFEditors: Wenger NK, Collins P.Taylor and Francis, Abingdon, UK2005
• Essential Atlas of Heart Diseases 
  Chapter: Atherosclerosis: Risk factors and treatment 
  Page 1 - 24Wilson PWFEditors: Braunwald, E.Current MedicineEdition 3rd,2005
• Atlas of Atherosclerosis 
  Chapter: Diabetes mellitus and vascular disease risk 
  Page 214 - 233Meigs JB, Wilson PWF, Goldberg IJ, Semenkovich CF, Ginsberg HNEditors: Grundy S.Current MedicineEdition 4th,2005
• Atlas of Atherosclerosis 
  Chapter: The newer coronary risk factors 
  Page 169 - 185Wilson PWFEditors: Grundy S.Current MedicineEdition 4th,2005
• Molecular mechanisms of atherosclerosis 
  Chapter: The epidemiology of atherosclerotic disease. Chapter 2 
  Page 3 - 28Wilson PWFEditors: J Loscalzo.Taylor & Francis, London2005
• Harrison's Advances in Cardiology 
  Chapter: Homocysteine, vitamins and coronary artery disease. 
  Page 18 - 23Wilson P.W.F.Editors: Braunwald E.McGraw-Hill, New York2002
• Homocysteine and Vascular Disease 
  Chapter: Epidemiology of homocysteine levels and relation to vitamins 
  Page 85 - 95Wilson PWF, Jacques PFEditors: K. Robinson.Kluwer Academic Publishers, Amsterdam2000
• Handbook of Hypertension, Volume 20: Epidemiology of Hypertension 
  Chapter: Hypertension as a cardiovascular risk factor 
  Page 19 - 42Kannel WB, Wilson PWFEditors: C. J. Bulpitt.Elsevier Press, Amsterdam2000
• Atlas of Atherosclerosis: Risk Factors and Treatment 
  Chapter: The newer coronary risk factors 
  Page 180 - 193Wilson PWFEditors: PWF Wilson.Current Science 2000, Philadelphia, PAEdition 2nd,2000
• Statins: The HMG CoA Reductase Inhibitors in Perspective 
  Chapter: Lipid control in the pre-statin era. 
  Page 21 - 34Kannel WB, Wilson PWFEditors: Gaw A, Packard CJ, Shepherd J.Dunitz Press, London1999
• Cardiovascular Disease in the Octogenarian and Beyond 
  Chapter: Coronary risk factors and coronary prevention in octogenarians 
  Page 141 - 161Kannel WB, Wilson PWF, Larson MG, Evans JCEditors: Wenger NK.Dunitz Press1999
• Atherosclerosis XI 
  Chapter: Secular trends in cardiovascular risk factor levels: a Framingham perspective. 
  Page 659 - 664Wilson PWF, D’Agostino RB, Kannel WBEditors: B. Jacotot, D. Mathe, J-C Fruchart.Elsevier Press, Singapore1998
• Preventive Cardiology 
  Chapter: Diabetes mellitus, insulin resistance and CHD 
  Page 69 - 96Wilson PWFEditors: Robinson K.Futura, New York1998
• Preventive Cardiology 
  Chapter: Physical activity and CHD 
  Page 51 - 67Wilson PWFEditors: Robinson K.Futura, New York1998
• Atherosclerosis XI 
  Chapter: Advances in cardiovascular risk prediction: new biochemical and genetic markers. 
  Page 425 - 431Ordovas JM, Cupples LA, Wilson PWF, Lahoz C, Levy D, Otvos JD, McNamara JR, Gagne E, Hayden M, Schaefer EJEditors: B. Jacotot, D. Mathe, J-C Fruchart.Elsevier Press, Singapore1998
• Multiple Risk Factors in Cardiovascular Disease 
  Chapter: Epidemiology of risk factor clustering in elevated blood pressure 
  Page 325 - 333Editors: Gotto Jr AM et al.Kluwer, Netherlands1998
• Textbook of Cardiovascular Medicine 
  Chapter: Atherosclerotic Cardiovascular Disease : An epidemiologic perspecitive 
  Page 13 - 30Levy D, Wilson PWFEditors: Topol E.Lippincott-Raven1997
• Surrogate markers to assess efficacy of treatment in chronic liver disease. 
  Chapter: Surrogate markers and prediction of cardiovascular disease (chapter 2) 
  Page 8 - 18Wilson PWFEditors: Reichen R.E.. & Reichen J.Kluwer1996
• Atlas of Heart Diseases; Volume X Atherosclerosis: Risk factors and treatment 
  Chapter: The Newer Coronary Risk Factors (chapter 10). 
  Wilson PWF, Castelli WPEditors: E. Braunwald; Brown,W.V. (Volume Editor).Mosby, St. Louis1996
•  
  Chapter: Apolipoprotein E allele 4 is associated with dementia in the Framingham Study 
  Page 63 - 70Myers RH, Schaefer EJ, Wilson PWF, D'Agostino R, Bachman DL, Ordovas JM, Au R, Cobb JL, Wolf PAEditors: Iqbal K, Mortimer JA, Winblad B, Wisniewski HM.Wiley & Sons1995
• Hypertension: Physiology, Diagnosis, and Management. 
  Chapter: Chapter 7: Hypertension, other risk factors, and the risk of cardiovascular disease. 
  Page 99 - 114Wilson PWF, Kannel WBEditors: Laragh JH and Brenner BM.Raven Press, New YorkEdition 2nd,1995
• Hypertension Primer: The Essentials of High Blood Pressure 
  Chapter: Chapter C17: Total Cardiovascular Risk 
  Page 190 - 191Wilson PWFEditors: Izzo JL and Black HR.American Heart Association1993
• Coronary Risk Factors and Their Assessment 
  Thompson GR, Wilson PWFScience Press, London1992
• Join now to see all